1. Homepage
  2. Equities
  3. China
  4. Shanghai Stock Exchange
  5. Shanghai MicroPort Endovascular MedTech Co., Ltd.
  6. News
  7. Summary
    688016   CNE100003MJ5

SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.

(688016)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Shanghai Microport Endovascular Medtech Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021

08/25/2021 | 05:55am EDT

Shanghai MicroPort Endovascular MedTech Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 362.274 million compared to CNY 214.842 million a year ago. Operating income was CNY 215.656 million compared to CNY 140.972 million a year ago. Net income was CNY 184.704 million compared to CNY 120.538 million a year ago. Basic earnings per share from continuing operations was CNY 2.57 compared to CNY 1.67 a year ago.


© S&P Capital IQ 2021
All news about SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
04/29Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Firs..
CI
03/31UBS Adjusts Shanghai MicroPort Endovascular MedTech's Price Target to 250 Yuan From 239..
MT
03/21UBS Adjusts Shanghai MicroPort Endovascular MedTech's Price Target to 239 Yuan From 424..
MT
02/25Shanghai MicroPort Endovascular's Profit Jumps Over 47% in 2021; Shares Surge 10%
MT
02/24Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Full..
CI
01/24MicroPort Scientific Projects up to 50% Jump in Unit's 2021 Profit
MT
01/24Shanghai MicroPort Endovascular MedTech Co., Ltd. Provides Earnings Guidance for the Ye..
CI
2021Shanghai MicroPort Endovascular MedTech Co., Ltd. Reports Earnings Results for the Nine..
CI
2021Shanghai MicroPort Endovascular MedTech Co., Ltd. Announces Unaudited Financial Results..
CI
2021Shanghai Microport Endovascular Medtech Co., Ltd. Reports Earnings Results for the Half..
CI
More news
Analyst Recommendations on SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
More recommendations
Financials
Sales 2022 942 M 142 M 142 M
Net income 2022 423 M 63,6 M 63,6 M
Net cash 2022 1 458 M 219 M 219 M
P/E ratio 2022 29,2x
Yield 2022 1,64%
Capitalization 12 328 M 1 853 M 1 853 M
EV / Sales 2022 11,5x
EV / Sales 2023 8,31x
Nbr of Employees 660
Free-Float 48,5%
Chart SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
Duration : Period :
Shanghai MicroPort Endovascular MedTech Co., Ltd. Technical Analysis Chart | 688016 | CNE100003MJ5 | MarketScreener
Technical analysis trends SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 171,53 CNY
Average target price 243,00 CNY
Spread / Average Target 41,7%
EPS Revisions
Managers and Directors
Qing Zhu General Manager & Director
Chun Fang Li Chief Financial Officer
Bo Peng Chairman
Cheng Yun Yue Chairman-Supervisory Board
Bao Lin Liu Independent Director
Sector and Competitors